Drugs / BAY-784
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02212080 | Sep 2014 → Mar 2015 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY-784 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4537788 ↗ |
| Known as | BAY1214784 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02212080 ↗ |
| Route | Oral | “Increasing Single Oral Doses (5-1000 mg, Solution)” NCT02212080 ↗ |